Source / episode info
- **Episode:**161
- **Title:**Divine Intervention Episode 161 – The Clutch Auto-antibody Podcast.
- **Published:**2019-09-25
- Source:Episode page
One-liner
This episode provides a comprehensive review of high-yield autoantibodies associated with various autoimmune conditions, including Rheumatoid Arthritis (Anti-CCP), Lupus (Anti-dsDNA/Sm), Sjögren's Syndrome (Anti-Ro/La), vasculitides (p-ANCA), myositis (Anti-Jo-1, Anti-Mi-2), and dermatologic blistering diseases.
High-yield summary
- Rheumatoid Arthritis: While Rheumatoid Factor (RF) is sensitive (~80%), the most specific antibody for diagnosis is Anti-CCP (anti-cyclic citrullinated peptide).
- Lupus Spectrum: Anti-dsDNA and Anti-Sm are highly specific markers for SLE. Anti-Ro/La antibodies are associated with Sjögren's syndrome, but also cross the placenta, risking fetal heart block.
- Myositis Panel: The panel of myositis antibodies includes Anti-Jo-1, Anti-Mi-2, and Anti-SRP. These help classify the specific inflammatory myopathy.
- Dermatologic Antibodies: Pemphigus Vulgaris targets desmosomes (e.g., Anti-Desmoglein), while Bullous Pemphigoid targets hemidesmosomes.
- Systemic Vasculitis Markers: p-ANCA is associated with a triad of vasculitides: Granulomatosis with polyangiitis, Microscopic Polyangiitis, and Eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
- Endocrine/Neuro Antibodies: Anti-AChR antibodies are classic for Myasthenia Gravis; Anti-TPO/Anti-Tg are markers for Hashimoto's thyroiditis.
Learning objectives
- Identify the specific autoantibody associated with major connective tissue diseases (e.g., SLE, Sjögren's, Scleroderma).
- Differentiate between antibody targets in blistering skin diseases (desmosomes vs. hemidesmosomes).
- Recognize the clinical significance of p-ANCA and its association with small vessel vasculitis.
- Correlate specific antibodies (e.g., Anti-GAD, Anti-TPO) with their respective endocrine disorders (Type 1 Diabetes, Hashimoto's).
- Understand the differential diagnosis between various inflammatory myopathies based on antibody profile.